Knowledge-graph AI prioritizes TPP1 as a Parkinson’s disease target linked to α-synuclein homeostasis
Standigm ASK’s knowledge-graph model ranked Parkinson’s disease target associations; subgraph enrichment and expression analyses narrowed 2,527 predicted targets to five candidates, including TPP1. In a human cell-based α-synuclein seeding model, TPP1 knockdown increased aggregate accumulation and insoluble α-synuclein, experimentally supporting a TPP1–α-synuclein relationship and a possible protective role.
Technology: Standigm ASK knowledge-graph path-based deep-learning model with subgraph-level over-representation re-ranking
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: In a human cell-based α-synuclein seeding model, TPP1 knockdown increased aggregate accumulation and insoluble α-synuclein, experimentally supporting a TPP1–α-synuclein relationship and a possible protective role.
- Still unknown: The functional experiment is a human neuroblastoma cell model exposed to α-synuclein preformed fibrils, not a clinical or in-vivo therapeutic demonstration. Knockdown increasing aggregation supports a protective association; direct enzymatic cleavage of α-synuclein is proposed from structural modeling, not established by the reported work. TPP1 is a candidate therapeutic target, not a validated treatment.
- AI role: The model integrated heterogeneous biomedical databases, encoded relational paths using a convolutional network and attention aggregation, and produced disease-target scores. Researchers applied enrichment and transcriptomic filters to prioritize TPP1, then validated TPP1’s relationship to α-synuclein aggregation via siRNA knockdown and cellular assays; AlphaFold-Multimer modeling suggested, but did not prove, direct proteolysis.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12814083/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.